Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
5 pending office actions • 3 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready
Trait Biosciences, Inc. has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 4 actions are spread across 3 distinct art units, showing a level of technical diversity within the biotech field. The prosecution is further distributed among 4 distinct examiners, meaning no two pending actions are being reviewed by the same person.
JASON DEVEAU ROSEN is the busiest examiner for the company, currently handling 1 pending office action. This single action represents a portion of the total 4 pending actions in the portfolio. With 3 distinct art units involved, the company must address different sets of examination guidelines while managing the individual expectations of the 4 distinct examiners currently reviewing their applications.
The presence of 4 pending office actions across 3 distinct art units suggests that the company's pharmaceutical and biotechnological claims are categorized into several specialized areas. Since 4 distinct examiners are involved, the company faces four unique perspectives on its patentability. Success in the Biotechnology & Pharmaceuticals sector will require a tailored approach for each of the 4 pending actions.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §112 only | 1 (20%) |
| Double-patenting + other | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DEVEAU ROSEN, JASON | 1 | 80.1% | +16.5% |
| FETTEROLF, BRANDON J | 1 | 52.0% | +17.4% |
| KOVALENKO, MYKOLA V | 1 | 69.5% | +25.8% |
| MOEHLMAN, ANDREW TERRY | 1 | 66.3% | +61.0% |
| TSAY, MARSHA M | 1 | 45.7% | +52.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19290958 | Novel Systems, Methods, And Compositions For The Glycosylation Of Cannabinoid Compounds | DEVEAU ROSEN, JASON | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17428581 | Generation Of Water-Soluble Cannabinoids Utilizing Protein Cannabinoid-Carriers | TSAY, MARSHA M | 34d |
| 18678152 | WATER-SOLUBLE CANNABINOID PRODRUGS COMPOSITIONS AND METHODS OF SYNTHESIZING THE SAME | FETTEROLF, BRANDON J | — |
| 18430133 | PRODUCTION OF CANNABINOID GLYCOSIDE COMPOUNDS IN CELL CULTURE | KOVALENKO, MYKOLA V | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17428581 | Generation Of Water-Soluble Cannabinoids Utilizing Protein Cannabinoid-Carriers | TSAY, MARSHA M | 34d |
| 19290958 | Novel Systems, Methods, And Compositions For The Glycosylation Of Cannabinoid Compounds | DEVEAU ROSEN, JASON | — |
| 18678152 | WATER-SOLUBLE CANNABINOID PRODRUGS COMPOSITIONS AND METHODS OF SYNTHESIZING THE SAME | FETTEROLF, BRANDON J | — |
| 18430133 | PRODUCTION OF CANNABINOID GLYCOSIDE COMPOUNDS IN CELL CULTURE | KOVALENKO, MYKOLA V | — |
| 18364273 | WATER-SOLUBLE CANNABINOID FOOD AND BEVERAGE ADDITIVE HAVING ENHANCED STABILITY | MOEHLMAN, ANDREW TERRY | — |
| Art Unit | Apps |
|---|---|
| 1662 | 2 |
| 1655 | 1 |
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19290958 | Novel Systems, Methods, And Compositions For The Glycosylation Of Cannabinoid Compounds | DEVEAU ROSEN, JASON | 1662 | §112 | Non-Final OA | — | Pending | Aug 05, 2025 |
| 18678152 | WATER-SOLUBLE CANNABINOID PRODRUGS COMPOSITIONS AND METHODS OF SYNTHESIZING THE SAME | FETTEROLF, BRANDON J | — | §102§112 | Non-Final OA | — | Pending | May 30, 2024 |
| 18430133 | PRODUCTION OF CANNABINOID GLYCOSIDE COMPOUNDS IN CELL CULTURE | KOVALENKO, MYKOLA V | 1662 | §103§112 | Non-Final OA | — | Pending | Feb 01, 2024 |
| 18364273 | WATER-SOLUBLE CANNABINOID FOOD AND BEVERAGE ADDITIVE HAVING ENHANCED STABILITY | MOEHLMAN, ANDREW TERRY | 1655 | §102§103§112DP | Non-Final OA | — | Pending | Aug 02, 2023 |
| 17428581 | Generation Of Water-Soluble Cannabinoids Utilizing Protein Cannabinoid-Carriers | TSAY, MARSHA M | 1656 | §101§102§103§112 | Non-Final OA | 34d | Pending | Aug 04, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial